Literature DB >> 34282393

Prevalence and risk factors of diabetic retinopathy in patients with type 2 diabetes in Shanghai.

Pei Zhang1, Wen-Wen Xue2, Xiao-Bo Huang3, Yi Xu2, Li-Na Lu2, Kai-Rong Zheng4, Hai-Dong Zou2,4.   

Abstract

AIM: To investigate the prevalence of diabetic retinopathy (DR) in residents of Shanghai and analyze the risk factors of DR.
METHODS: This study involved 7233 patients with diabetes in 2016. The demographic data of the participants were collected using a questionnaire survey. Physical examination, laboratory tests, and ophthalmological examinations were conducted. Two professional ophthalmologists diagnosed and graded DR by fundus examination and then combined the results with fundus images. The unconditional multivariate Logistic regression analysis was used to determine the risk factors.
RESULTS: In total, 6978 patients with type 2 diabetes in Shanghai with a mean age of 68.33±8.40y were recruited, including 2975 males (42.6%) and 4003 females (57.4%). Overall, 1184 patients were diagnosed with DR, with a prevalence rate of 16.97%. Regression analysis showed that duration of diabetes (OR 1.061, 95%CI 1.049-1.073), high systolic blood pressure (SBP; OR 1.071, 95%CI 1.037-1.106), increased glycosylated hemoglobin level (OR 1.234, 95%CI 1.162-1.311), high blood glucose level (OR 1.061, 95%CI 1.023-1.099), increased neutrophil-to-lymphocyte ratio (NLR; OR 1.132, 95%CI 1.053-1.217) and mean platelet volume (MPV; OR 1.077, 95%CI 1.016-1.142) were risk factors of DR. Conversely, hematocrit (HCT; OR 0.971, 95%CI 0.954-0.988) and mean corpuscular volume (MCV; OR 0.980, 95%CI 0.965-0.994) were protective factors.
CONCLUSION: The prevalence rate of DR in Shanghai is 16.97%. The duration of diabetes, high SBP, increased glycosylated hemoglobin, NLR, and MPV were determined as risk factors of DR. International Journal of Ophthalmology Press.

Entities:  

Keywords:  diabetic retinopathy; neutrophil-to-lymphocyte ratio; prevalence; type 2 diabetes

Year:  2021        PMID: 34282393      PMCID: PMC8243199          DOI: 10.18240/ijo.2021.07.16

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  36 in total

Review 1.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

2.  Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study.

Authors:  Yingfeng Zheng; Ecosse L Lamoureux; Raghavan Lavanya; Renyi Wu; M Kamran Ikram; Jie Jin Wang; Paul Mitchell; Ning Cheung; Tin Aung; Seang-Mei Saw; Tien Y Wong
Journal:  Ophthalmology       Date:  2012-06-17       Impact factor: 12.079

Review 3.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Authors:  Daniel Shu Wei Ting; Gemmy Chui Ming Cheung; Tien Yin Wong
Journal:  Clin Exp Ophthalmol       Date:  2016-02-17       Impact factor: 4.207

4.  Neutrophil-to-Lymphocyte Ratio Increases in Patients With Dry Eye.

Authors:  Berrak Sekeryapan; Feyzahan Uzun; Seyma Buyuktarakci; Asker Bulut; Veysi Oner
Journal:  Cornea       Date:  2016-07       Impact factor: 2.651

5.  Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus.

Authors:  Ze-Long Zhong; Mei Han; Song Chen
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

6.  Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis.

Authors:  Jeany Q Li; Thomas Welchowski; Matthias Schmid; Julia Letow; Caroline Wolpers; Isabel Pascual-Camps; Frank G Holz; Robert P Finger
Journal:  Eur J Epidemiol       Date:  2019-09-12       Impact factor: 8.082

7.  Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.

Authors:  Gülay Ulusal Okyay; Salih Inal; Kürşad Oneç; Ramazan Erdem Er; Ozge Paşaoğlu; Hatice Paşaoğlu; Ulver Derici; Yasemin Erten
Journal:  Ren Fail       Date:  2012-11-01       Impact factor: 2.606

8.  Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.

Authors:  Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia Jenkins; Jonathan Shaw; Jie Jin Wang
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

9.  The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.

Authors:  Peiyao Jin; Jinjuan Peng; Haidong Zou; Weiwei Wang; Jiong Fu; Binjie Shen; Xuelin Bai; Xun Xu; Xi Zhang
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 10.  Diabetic Retinopathy: Pathophysiology and Treatments.

Authors:  Wei Wang; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

View more
  3 in total

1.  Prevalence of and risk factors for diabetic retinopathy in residents with different types of abnormal glucose metabolism with or without hypertension: A suburban community-based cross-sectional study.

Authors:  Yuhang Ma; Hao Wang; Junyi Jiang; Changjing Han; Chunhua Lu; Siliang Zeng; Yufan Wang; Zhi Zheng; Yongde Peng; Xiaoying Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

2.  Emerging Trends and Research Foci in Artificial Intelligence for Retinal Diseases: Bibliometric and Visualization Study.

Authors:  Junqiang Zhao; Yi Lu; Yong Qian; Yuxin Luo; Weihua Yang
Journal:  J Med Internet Res       Date:  2022-06-14       Impact factor: 7.076

3.  Prevalence and risk factors of diabetic retinopathy among Chinese adults with type 2 diabetes in a suburb of Shanghai, China.

Authors:  Huiling Tan; Xin Wang; Kaiyou Ye; Jianmin Lin; E Song; Lihua Gong
Journal:  PLoS One       Date:  2022-10-04       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.